The U.S. Pharmacovigilance Automation Market is projected to grow from USD 0.94 Billion in 2025 to USD 1.52 Billion by 2035, while Europe is expected to expand from USD 0.34 Billion to USD 1.92 Billion, supported by increasing AI adoption, stringent drug safety regulations, and rising adverse event reporting volumes.
The U.S. Pharmacovigilance Automation Market is projected to grow from USD 0.94 Billion in 2025 to USD 1.52 Billion by 2035, while Europe is expected to expand from USD 0.34 Billion to USD 1.92 Billion, supported by increasing AI adoption, stringent drug safety regulations, and rising adverse event reporting volumes.